永久性填充物——它们的作用是什么

Lina Chan, Andraia Li, Todd Schlesinger
{"title":"永久性填充物——它们的作用是什么","authors":"Lina Chan,&nbsp;Andraia Li,&nbsp;Todd Schlesinger","doi":"10.1002/der2.189","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>With the growing cosmetic industry, there have been numerous advancements in nonsurgical interventions including the use of permanent dermal filler injections. Permanent fillers are relatively novel in clinical use when compared to temporary and semi-permanent fillers. The only FDA-approved, non-biodegradable permanent filler uses polymethylmethacrylate (PMMA) microspheres. PMMA is suspended in bovine collagen and lidocaine solution for injection, absorbed by the body, and replaced overtime by collagen. ArteFill® was the first FDA approved permanent filler in 2005 for correction of nasolabial folds, with studies demonstrating rejuvenation for up to five years, trumping its predecessors in longevity. A decade later with rebranding, Bellafill® was indicated for correction of nasolabial fold and atrophic acne scars.</p>\n </section>\n \n <section>\n \n <h3> Aims</h3>\n \n <p>To review the development of permanent fillers, mechanism, and safety.</p>\n </section>\n \n <section>\n \n <h3> Materials &amp; Methods</h3>\n \n <p>A qualitative systematic review was conducted on PMMA microspheres indications, contraindications, and off-label use on benefits, risks, and adverse events.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>The durability of permanent fillers has a strong appeal for both patients and practitioners, however, usage for certain patient populations demonstrates increased risk for both early and late complications compared to temporary and semi-permanent fillers. A skin test composed of purified 3.5% bovine collagen gel administered in the volar forearm is recommended one month prior to injection, to identify any patients who may have a positive response. Bovine collagen demonstrates low immunogenicity with the incidence of preexisting hypersensitivity reported to be between 2-4%. Bovine collagen in dermatologic formulations use pepsin-solubilized formulations in which telopeptides are cleaved to further help reduce aberrant immunogenic responses.</p>\n </section>\n \n <section>\n \n <h3> Discussion</h3>\n \n <p>Early and late complications may outweigh the benefits in use of permanent fillers, however these complications are patient dependent.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Permanent fillers may be useful in volume replacement for nasolabial folds and atrophic acne scars, however a provider must use good clinical judgement in deciding which patients are ideal candidates.</p>\n </section>\n </div>","PeriodicalId":100366,"journal":{"name":"Dermatological Reviews","volume":"4 3","pages":"121-126"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Permanent fillers—What is their role\",\"authors\":\"Lina Chan,&nbsp;Andraia Li,&nbsp;Todd Schlesinger\",\"doi\":\"10.1002/der2.189\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>With the growing cosmetic industry, there have been numerous advancements in nonsurgical interventions including the use of permanent dermal filler injections. Permanent fillers are relatively novel in clinical use when compared to temporary and semi-permanent fillers. The only FDA-approved, non-biodegradable permanent filler uses polymethylmethacrylate (PMMA) microspheres. PMMA is suspended in bovine collagen and lidocaine solution for injection, absorbed by the body, and replaced overtime by collagen. ArteFill® was the first FDA approved permanent filler in 2005 for correction of nasolabial folds, with studies demonstrating rejuvenation for up to five years, trumping its predecessors in longevity. A decade later with rebranding, Bellafill® was indicated for correction of nasolabial fold and atrophic acne scars.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Aims</h3>\\n \\n <p>To review the development of permanent fillers, mechanism, and safety.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Materials &amp; Methods</h3>\\n \\n <p>A qualitative systematic review was conducted on PMMA microspheres indications, contraindications, and off-label use on benefits, risks, and adverse events.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>The durability of permanent fillers has a strong appeal for both patients and practitioners, however, usage for certain patient populations demonstrates increased risk for both early and late complications compared to temporary and semi-permanent fillers. A skin test composed of purified 3.5% bovine collagen gel administered in the volar forearm is recommended one month prior to injection, to identify any patients who may have a positive response. Bovine collagen demonstrates low immunogenicity with the incidence of preexisting hypersensitivity reported to be between 2-4%. Bovine collagen in dermatologic formulations use pepsin-solubilized formulations in which telopeptides are cleaved to further help reduce aberrant immunogenic responses.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Discussion</h3>\\n \\n <p>Early and late complications may outweigh the benefits in use of permanent fillers, however these complications are patient dependent.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>Permanent fillers may be useful in volume replacement for nasolabial folds and atrophic acne scars, however a provider must use good clinical judgement in deciding which patients are ideal candidates.</p>\\n </section>\\n </div>\",\"PeriodicalId\":100366,\"journal\":{\"name\":\"Dermatological Reviews\",\"volume\":\"4 3\",\"pages\":\"121-126\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-04-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Dermatological Reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/der2.189\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatological Reviews","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/der2.189","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景随着化妆品行业的发展,在非手术干预方面取得了许多进展,包括使用永久性真皮填充物注射。与临时和半永久性填料相比,永久性填料在临床应用中是相对新颖的。美国食品药品监督管理局唯一批准的不可生物降解的永久性填料使用聚甲基丙烯酸甲酯(PMMA)微球。PMMA悬浮在注射用牛胶原蛋白和利多卡因溶液中,被身体吸收,并随着时间的推移被胶原蛋白取代。ArteFill®是美国食品药品监督管理局于2005年批准的第一种用于矫正鼻唇沟的永久性填充物,研究表明,它可以恢复长达五年的活力,在寿命方面胜过其前身。十年后,随着品牌重塑,Bellafill®被用于矫正鼻唇沟和萎缩性痤疮疤痕。目的综述永久性填料的发展、机理和安全性。材料&;方法对PMMA微球的适应症、禁忌症和标示外使用的益处、风险和不良事件进行定性系统评价。结果永久性填充物的耐用性对患者和从业者都有很大的吸引力,然而,与临时和半永久性填充器相比,某些患者群体的使用表明早期和晚期并发症的风险增加。建议在注射前一个月在前臂掌部进行由纯化的3.5%牛胶原蛋白凝胶组成的皮肤测试,以确定任何可能有阳性反应的患者。牛胶原蛋白表现出低免疫原性,据报道先前存在的超敏反应的发生率在2-4%之间。皮肤科制剂中的牛胶原蛋白使用胃蛋白酶溶解的制剂,其中末端肽被切割以进一步帮助减少异常免疫原性反应。讨论早期和晚期并发症可能超过使用永久性填充物的益处,但这些并发症取决于患者。结论永久性填充物可用于鼻唇沟和萎缩性痤疮疤痕的体积置换,但提供者必须使用良好的临床判断来决定哪些患者是理想的候选者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Permanent fillers—What is their role

Background

With the growing cosmetic industry, there have been numerous advancements in nonsurgical interventions including the use of permanent dermal filler injections. Permanent fillers are relatively novel in clinical use when compared to temporary and semi-permanent fillers. The only FDA-approved, non-biodegradable permanent filler uses polymethylmethacrylate (PMMA) microspheres. PMMA is suspended in bovine collagen and lidocaine solution for injection, absorbed by the body, and replaced overtime by collagen. ArteFill® was the first FDA approved permanent filler in 2005 for correction of nasolabial folds, with studies demonstrating rejuvenation for up to five years, trumping its predecessors in longevity. A decade later with rebranding, Bellafill® was indicated for correction of nasolabial fold and atrophic acne scars.

Aims

To review the development of permanent fillers, mechanism, and safety.

Materials & Methods

A qualitative systematic review was conducted on PMMA microspheres indications, contraindications, and off-label use on benefits, risks, and adverse events.

Results

The durability of permanent fillers has a strong appeal for both patients and practitioners, however, usage for certain patient populations demonstrates increased risk for both early and late complications compared to temporary and semi-permanent fillers. A skin test composed of purified 3.5% bovine collagen gel administered in the volar forearm is recommended one month prior to injection, to identify any patients who may have a positive response. Bovine collagen demonstrates low immunogenicity with the incidence of preexisting hypersensitivity reported to be between 2-4%. Bovine collagen in dermatologic formulations use pepsin-solubilized formulations in which telopeptides are cleaved to further help reduce aberrant immunogenic responses.

Discussion

Early and late complications may outweigh the benefits in use of permanent fillers, however these complications are patient dependent.

Conclusion

Permanent fillers may be useful in volume replacement for nasolabial folds and atrophic acne scars, however a provider must use good clinical judgement in deciding which patients are ideal candidates.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信